What Are the Signs a Neurofibroma Is Becoming MPNST?

Living with Neurofibromatosis type 1 (NF1) means monitoring multiple benign (non-cancerous) bumps and tumors. It is completely normal to feel anxious about these tumors, and one of the most common worries is knowing how to tell if a tumor is transforming into a rare cancer called a malignant peripheral nerve sheath tumor (MPNST).

Importantly, ordinary skin-level (cutaneous) neurofibromas almost never turn into cancer. The risk lies primarily in deep tumors, plexiform neurofibromas (complex tumors growing along nerves), and atypical neurofibromas (tumors that show unusual cell features but are not cancer). The most important warning signs that a deeper tumor might be changing include rapid growth, new persistent pain, a change to a hard texture, or new nerve numbness and weakness ^[1][2]. While a tumor larger than 5 centimeters does carry a higher contextual risk, a stable large tumor is not an emergency ^[3][4]. However, any rapid changes to a tumor of any size require prompt assessment by your care team ^[1][5].

Key Warning Signs to Watch For

Because it is impossible to evaluate every single bump every day, knowing the specific warning signs can help you identify when it is time to call your doctor. Remember that these signs mean the tumor needs assessment to determine if it is benign, atypical, or malignant—they do not mean it is definitely cancer.

• Rapid Growth: Plexiform neurofibromas can grow slowly over years. If a previously stable bump suddenly begins to enlarge quickly or accelerates its growth, you should schedule a prompt evaluation ^[1][2][5].
• New Onset of Pain: Many benign tumors can cause mild, chronic discomfort. However, new onset of persistent, deep pain, or severe pain that wakes you from sleep is a red flag ^[1][2]. Pain accompanied by a growing tumor is a primary reason to suspect an MPNST ^[5].
• Change in Texture: Benign neurofibromas typically feel relatively soft or rubbery. If a tumor—or a specific part of a tumor—becomes notably firm, hard, or fixed in place, this change should be assessed by your doctor ^[6][7].
• New Nerve Weakness or Numbness: Because these tumors grow along nerves, a rapidly growing or malignant tumor can damage nerve fibers. New focal neurological symptoms, such as weakness, numbness, tingling, or a loss of function in a limb, are critical signs of a changing tumor ^[1][2][5].
• Tumor Size > 5 Centimeters: While many benign plexiform neurofibromas are larger than 5 cm, cancer is more often found in tumors of this size ^[3][8]. Size is a risk factor, not a diagnostic cutoff ^[4]. If you have a large tumor, it does not mean you have an emergency, but it should be routinely monitored by your specialist.

When to Seek Care

Next Steps: What to Do If You Spot a Warning Sign

If you notice rapid changes, do not panic, but do not ignore them. Contact your NF1 specialist, neurologist, or primary clinician to request an expedited appointment. Keep a log of your symptoms or take dated photographs to help your doctor understand how quickly the changes are happening.

If your clinician is concerned, they will likely refer you to a multidisciplinary team (a group of different specialists who work together) at a sarcoma center (a hospital specializing in rare tissue cancers). The evaluation typically involves:

1. Clinical Exam: To check the tumor and your nerve function.
2. Magnetic Resonance Imaging (MRI): A scan that uses magnets to create a detailed picture of the tumor’s size, depth, and structure. MRI helps distinguish benign tumors from potentially malignant ones ^[9][4].
3. FDG-PET Scan: If the MRI looks suspicious, the team may selectively order a PET scan. This test highlights cells using excessive energy ^[9][10]. Note that high energy use does not guarantee cancer—inflammation and atypical (but benign) tumors can also light up on a PET scan ^[11].
4. Image-Guided Core Biopsy: If imaging strongly suggests malignancy, an expert will perform a core biopsy, using a hollow needle to remove a small cylinder of tissue ^[12][13]. Biopsies for nerve tumors require careful planning by the sarcoma team to avoid nerve injury. Because tumors can be mixed (heterogeneous), a biopsy might occasionally miss the cancerous cells, so expert pathology review is essential ^[14].